Koefisien rega marang bathi Amylyx Corp (AMLX)
The current price-to-earnings valuation allows for an analysis of investments in the neuroprotective developments of Amylyx Pharmaceuticals (AMLX). The company relies on its scientific potential in treating brain degeneration by creating combination therapies to protect neurons. However, the recall of its primary drug wiped out market advantages, necessitating an R&D restart. The latest parameter stands at -24.00, reflecting the order book's reaction to current capitalization risks.
Rincian analitis perusahaan Amylyx (AMLX)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Amylyx Pharmaceuticals|AMLX - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Amylyx Corp|AMLX - Gunggung utang perusahaan|Rasio utang marang aset resik Amylyx Pharmaceuticals, Inc.|AMLX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Amylyx Pharmaceuticals|Rasio jangkoan perantara amylyx.com
- data bathi bisnis lan rasio investasi:
AMLX - Bathi resik|Proyeksi bathi mangsa ngarep Amylyx Pharmaceuticals|AMLX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Amylyx Pharmaceuticals Inc|AMLX - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Amylyx Pharmaceuticals, Inc.|AMLX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Amylyx Pharmaceuticals|AMLX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan amylyx.com|AMLX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Amylyx Pharmaceuticals
- indikator volume dodolan lan pendapatan:
Analisis umum perusahaan:amylyx.com - AMLX
To find a fundamental floor, it is essential for an investor to evaluate the business value via the price-to-earnings ratio, which allows for the identification of undervalued assets and prevents overpaying for a fading business. By analyzing the quarterly P/E of Amylyx Pharmaceuticals (AMLX), one can compare market expectations with the actual commercialization efficiency of ALS therapy and the potential of the drug RELYVRIO, thereby determining the reliability of investments in the biotech sector.
Analisis perusahaan pesaing
Pangali P/E biogen.com|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Koefisien rega marang bathi Regencell Bioscience Ltd RGC|Axsome Therapeutics Inc - Koefisien rega marang bathi|ACADIA Corp (ACAD) - Kapitalisasi marang bathi|XENE - Rasio rega marang bathi|VKTX: Rasio rega marang bathi|SUPN (Supernus) - Koefisien rega marang bathi|Kapitalisasi marang bathi Catalyst Pharma (CPRX)|Koefisien rega marang bathi DNLI|Pangali rega marang bathi HRMY (Harmony Corp)|Koefisien rega marang bathi BHVN (Biohaven Ltd.)|TRVI (trevitherapeutics.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Praxis Precision Medicines, Inc. PRAX|AVXL (Anavex) - Kapitalisasi marang bathi resik|CeriBell Corp - Pangali P/E|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|ALEC: Pangali P/E|annexonbio.com (ANNX) - Pangali P/E|Rasio rega marang bathi Omeros Corp|NGNE: Nilai perusahaan marang bathi resik|Rasio rega marang bathi AC Immune Corp (ACIU)|Koefisien rega marang bathi Voyager Corp VYGR|Pangali P/E NMRA (Neumora Therapeutics)|Pangali P/E scilexholding.com SCLX|Tevogen Bio - Pangali P/E|Alpha Cognition (ACOG) - Koefisien rega marang bathi|CGTX: Pangali P/E|Kapitalisasi marang bathi Inhibikase Pharma (IKT)|Koefisien rega marang bathi SAVA|Pangali P/E Assertio Therapeutics|Koefisien rega marang bathi COYA (Coya Therapeutics, Inc.)|Rasio rega pasar marang bathi resik VTGN|Pangali P/E OVID (Ovid Therapeutics)|Periode bali modal bisnis Acumen Pharmaceuticals, Inc (ABOS)|CervoMed Inc. - Pangali P/E|Alterity Therapeutics (ATHE) - Koefisien rega marang bathi|CLNN: Pangali P/E|PepGen (PEPG) - Pangali P/E|Rasio rega marang bathi Jupiter Neurosciences|Rasio rega marang bathi RLMD|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|Periode bali modal bisnis gracetx.com|Pangali P/E AIFF (Firefly Neuroscience)|Pangali P/E ANEW Medical KLTO|NRSN - Rasio rega marang bathi|Reviva Pharmaceuticals, Inc. (RVPH) - Koefisien rega marang bathi|metaviatx.com (MTVA) - Rasio rega marang bathi|NRXS (neuraxis.com) - Rasio rega marang bathi|Koefisien rega marang bathi HSDT|Pangali rega marang bathi PASG (Passage Bio Corp)|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|Minerva - Pangali rega marang bathi|Pangali P/E ATHA (Athira Pharma, Inc.)|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|ALZN: Koefisien rega marang bathi|CYCN - Pangali P/E|protagenic.com (PTIX) - Rasio rega marang bathi|Pasithea Therapeutics Corp. - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Cortigent Inc|Kapitalisasi marang bathi avenuetx.com ATXI|Pangali P/E BCLI|Pangali P/E Cara Therapeutics Inc. (CARA)|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|ELYM - Koefisien rega marang bathi|ITCI: Koefisien rega marang bathi|Kapitalisasi marang bathi longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|NKGN (NKGen Biotech Inc) - Rasio rega marang bathi|Koefisien rega marang bathi NRBO|Kapitalisasi marang bathi Sage Therapeutics Inc SAGE|Koefisien rega marang bathi SNPX (Synaptogenix, Inc.)|trevena.com - Pangali rega marang bathi|Vigil Neuroscience, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik WENA|CERE - Rasio rega marang bathi
